ENOV - CIK 0001420800
Enovis CORP trades as ENOV and has a market capitalization of $1.28 B, making it the #2453 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $2.25B, up 6.7% from the prior year and net income of -$1.18B. This page tracks Enovis CORP through 1,645 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Enovis CORP's revenue declined from $3.19B to $2.25B, a compound annual decline rate of 3.8%. Net profit margin compressed from 4.0% to -52.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
First-quarter sales growth of 5% on a reported basis
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and use Conference ID: 3314793. A link to a replay of the call will also be available on the Enovis website later that day.
Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com
The largest companies sharing Enovis CORP's SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
Enovis CORP (ENOV) has a market capitalization of $1.28 B as of 2026-06-10, ranking #2453 among US-listed companies.
Enovis CORP reported revenue of $2.25B for fiscal year 2025, an increase of 6.7% year over year.
In its latest fiscal year Enovis CORP reported a net loss of $1.18B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.